Skip to main content
TipRanks
Go Ultimate75% OFF

LIGUA, Inc. (7090) AI Stock Analysis

0 Followers
JP:7090

LIGUA, Inc.

(TSE/TYO:7090)

Select Model
Rating:50Neutral
Price Target:JPY 813.00â–¼(-5.90% Downside)
Action:reiterated
Date:08/29/26

The overall score is constrained by a weak financial foundation, primarily due to high leverage and persistent losses, which are the most significant risk factors. While the company's ability to generate positive cash flow offers some stability, the negative P/E ratio underscores its lack of profitability. Positive technical momentum provides a near-term tailwind, but overbought signals warrant caution.

Positive Factors
Improving operating cash flowThe improvement in operating cash flow indicates that the business is currently converting operations into more liquidity, despite reported losses. If sustained, stronger internal cash generation can support working capital, debt servicing, and business continuity over the coming quarters.
Negative Factors
Contracting revenueTwo consecutive years of annual revenue contraction point to weakening commercial momentum rather than a single-period fluctuation. A smaller revenue base can reduce operating leverage, constrain investment capacity, and make it harder for the company to absorb fixed costs over the next several quarters.

LIGUA, Inc. (7090) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%40%JP:7090-3.68%EWJ+15.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 1.42B
Dividend Yield
―
Average Volume (3M)
1,591
Price to Earnings (P/E)
-7.6
Beta (1Y)
0.70
Revenue Growth
-8.27%
EPS Growth
37.34%
Country
Japan
Employees
129
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

LIGUA, Inc. Business Overview & Revenue Model

Company Description

Ligua Inc., founded in Osaka, Japan in 2004, operates as a consulting firm primarily offering management support services within the healthcare sector. The company's activities are structured across two main divisions: Orthopedic Clinic Solutions and...

LIGUA, Inc. Financial Statement Overview

Summary

Financial performance is mixed. Cash flow generation is a relative strength (Cash Flow Score: 75), but the Income Statement (Score: 35) shows declining revenue and persistent net losses, while the Balance Sheet (Score: 20) is highly leveraged with eroded equity, raising solvency concerns. The overall financial health is weak, with cash flow providing only a partial cushion.

Income Statement

35Negative

Balance Sheet

20Very Negative

Cash Flow

75Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.39B2.42B2.87B3.43B2.84B3.20B
Gross Profit1.37B1.42B1.71B1.88B1.22B1.63B
EBITDA-28.70M-67.19M-90.80M274.91M-258.56M359.47M
Net Income-185.00M-241.03M-301.00M104.08M-774.47M72.41M
Balance Sheet
Total Assets2.51B2.49B3.14B3.87B3.37B3.28B
Cash, Cash Equivalents and Short-Term Investments1.15B1.19B1.35B1.33B1.17B1.38B
Total Debt1.55B1.62B2.10B2.39B2.26B1.51B
Total Liabilities2.34B2.32B2.82B3.26B3.02B2.14B
Stockholders Equity167.44M176.88M319.81M604.90M353.17M1.14B
Cash Flow
Free Cash Flow0253.57M146.47M-5.19M-384.94M40.15M
Operating Cash Flow0263.68M163.38M2.83M-328.22M80.06M
Investing Cash Flow0-41.85M147.72M10.78M-600.71M-474.61M
Financing Cash Flow0-390.37M-290.02M137.19M716.85M-154.13M

LIGUA, Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price864.00

Price Trends

50DMA900.76Negative
100DMA856.86Positive
200DMA905.72Negative

Market Momentum

MACD-2.22Negative
RSI46.88Neutral
STOCH73.33Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7090, the sentiment is Negative. The current price of 864.00 is below the 20-day moving average (MA) of 868.65, below the 50-day MA of 900.76, and below the 200-day MA of 905.72, indicating a bearish trend. The MACD of -2.22 indicates Negative momentum. The RSI at 46.88 is Neutral, neither overbought nor oversold. The STOCH value of 73.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7090.

LIGUA, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:7090 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:7741JP:774188OutperformJPY 7.84T28.0127.70%1.28%13.02%38.15%
JP:5889JP:588969NeutralJPY 50.40B11.69―4.10%15.36%5.16%
JP:3046JP:304667NeutralJPY 156.38B19.9722.48%1.59%14.41%-6.42%
JP:7780JP:778055NeutralJPY 148.30B23.006.65%1.42%5.60%25.38%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
JP:7743JP:774351NeutralJPY 23.79B28.57―1.91%4.13%-39.39%
JP:7090JP:709050NeutralJPY 1.54B-7.64――-8.27%37.34%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%JP:7090JP:7741JP:3046JP:7780JP:5889JP:7743Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:7090 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:7090LIGUA, Inc.864.00-87.00-9.15%
JP:7741HOYA CORPORATION23480.00675.172.96%
JP:3046JINS HOLDINGS 6550.00581.029.73%
JP:7780Menicon Co 1973.00580.2341.66%
JP:5889Japan Eyewear Holdings Co.,Ltd.2072.00265.5514.70%
JP:7743Seed Co., Ltd.786.00231.6341.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 29, 2026